Question 1

What are the differences between the follow-up methods being tested?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the EUFURO - EUS-based Follow-Up on R0-resected Patients for Esophageal, Gastric and Pancreatic Cancer clinical trial (NCT02209415). Contact the study team or your healthcare provider for specific answers.

Question 2

How might the imaging tests (EUS and PET/CT) help in monitoring my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the EUFURO - EUS-based Follow-Up on R0-resected Patients for Esophageal, Gastric and Pancreatic Cancer clinical trial (NCT02209415). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential risks or side effects of the imaging procedures?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the EUFURO - EUS-based Follow-Up on R0-resected Patients for Esophageal, Gastric and Pancreatic Cancer clinical trial (NCT02209415). Contact the study team or your healthcare provider for specific answers.

Question 4

How often would I need to come in for visits or tests if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the EUFURO - EUS-based Follow-Up on R0-resected Patients for Esophageal, Gastric and Pancreatic Cancer clinical trial (NCT02209415). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if the tests show signs of cancer returning?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the EUFURO - EUS-based Follow-Up on R0-resected Patients for Esophageal, Gastric and Pancreatic Cancer clinical trial (NCT02209415). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there other follow-up options available outside of this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the EUFURO - EUS-based Follow-Up on R0-resected Patients for Esophageal, Gastric and Pancreatic Cancer clinical trial (NCT02209415). Contact the study team or your healthcare provider for specific answers.

What this study is about